<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(1)</volume><submitter>Liu R</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To identify the specific risk factors associated with unexplained infertility (UI) among infertile couples.&lt;h4>Methods&lt;/h4>We conducted a retrospective cohort study analyzing UI risk factors, focusing on 5465 infertile couples who completed their first full in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycle out of a total cohort of 62201 infertile couples.&lt;h4>Results&lt;/h4>Among 5465 UI couples, 3400 achieved a live birth (cumulative live birth rate = 62.2%). Multivariate logistic regression indicated the key negative predictors included: female age ≥ 35 years (odds ratio [OR]: 0.63; 95% confidence interval [CI]: 0.51-0.78; &lt;i>p &lt;&lt;/i> 0.001), male age (OR: 0.98; 95% CI: 0.96-0.99; &lt;i>p =&lt;/i> 0.015), Female body mass index ≥ 27.5 kg/m&lt;sup>2&lt;/sup> (OR: 0.78; 95% CI: 0.62-0.97; &lt;i>p =&lt;/i> 0.028), low anti-Müllerian hormone (AMH) (AMH &lt; 1.2 ng/mL) (OR: 0.64; 95% CI: 0.52-0.77; &lt;i>p &lt;&lt;/i> 0.001), and a mid-range endometrial thickness (EMT) (EMT 0.7-1.0 cm) (OR: 0.77; 95% CI: 0.66-0.89; &lt;i>p &lt;&lt;/i> 0.001). A higher number of retrieved oocytes positively correlated with cumulative live birth (CLB) (OR: 1.02; 95% CI: 1.01-1.04; &lt;i>p =&lt;/i> 0.039).&lt;h4>Conclusion&lt;/h4>The prevalence of UI was 8.8% in our population, with 62.2% achieving CLB after one complete IVF/ICSI cycle. Female age and ovarian reserve indicators emerged as the main factors influencing oocyte yield, embryo acquisition, and CLB outcomes in UI patients.</pubmed_abstract><journal>Reproductive medicine and biology</journal><pagination>e70025</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12907981</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Analysis of Risk Factors Affecting Cumulative Live Birth in Couples With Unexplained Infertility Undergoing IVF/ICSI.</pubmed_title><pmcid>PMC12907981</pmcid><pubmed_authors>Ding G</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Ma Z</pubmed_authors><pubmed_authors>Ma J</pubmed_authors><pubmed_authors>Wu T</pubmed_authors><pubmed_authors>Dang Y</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of Risk Factors Affecting Cumulative Live Birth in Couples With Unexplained Infertility Undergoing IVF/ICSI.</name><description>&lt;h4>Purpose&lt;/h4>To identify the specific risk factors associated with unexplained infertility (UI) among infertile couples.&lt;h4>Methods&lt;/h4>We conducted a retrospective cohort study analyzing UI risk factors, focusing on 5465 infertile couples who completed their first full in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycle out of a total cohort of 62201 infertile couples.&lt;h4>Results&lt;/h4>Among 5465 UI couples, 3400 achieved a live birth (cumulative live birth rate = 62.2%). Multivariate logistic regression indicated the key negative predictors included: female age ≥ 35 years (odds ratio [OR]: 0.63; 95% confidence interval [CI]: 0.51-0.78; &lt;i>p &lt;&lt;/i> 0.001), male age (OR: 0.98; 95% CI: 0.96-0.99; &lt;i>p =&lt;/i> 0.015), Female body mass index ≥ 27.5 kg/m&lt;sup>2&lt;/sup> (OR: 0.78; 95% CI: 0.62-0.97; &lt;i>p =&lt;/i> 0.028), low anti-Müllerian hormone (AMH) (AMH &lt; 1.2 ng/mL) (OR: 0.64; 95% CI: 0.52-0.77; &lt;i>p &lt;&lt;/i> 0.001), and a mid-range endometrial thickness (EMT) (EMT 0.7-1.0 cm) (OR: 0.77; 95% CI: 0.66-0.89; &lt;i>p &lt;&lt;/i> 0.001). A higher number of retrieved oocytes positively correlated with cumulative live birth (CLB) (OR: 1.02; 95% CI: 1.01-1.04; &lt;i>p =&lt;/i> 0.039).&lt;h4>Conclusion&lt;/h4>The prevalence of UI was 8.8% in our population, with 62.2% achieving CLB after one complete IVF/ICSI cycle. Female age and ovarian reserve indicators emerged as the main factors influencing oocyte yield, embryo acquisition, and CLB outcomes in UI patients.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan-Dec</publication><modification>2026-07-09T11:08:55.194Z</modification><creation>2026-07-09T10:41:36.127Z</creation></dates><accession>S-EPMC12907981</accession><cross_references><pubmed>41705274</pubmed><doi>10.1002/rmb2.70025</doi></cross_references></HashMap>